Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Buy
62
MEDP Quote, Financials, Valuation and Earnings
Last price:
$569.62
Seasonality move
:
-3.36%
Day range:
$565.71 - $577.40
52-week range:
$250.05 - $626.26
Dividend yield:
0%
P/E ratio:
39.86x
P/S ratio:
7.31x
P/B ratio:
54.68x
Volume:
133.2K
Avg. volume:
249.9K
1-year change:
67.09%
Market cap:
$16.1B
Revenue:
$2.1B
EPS (TTM):
$14.30
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
$641M | $3.57 | 28.5% | 14.5% | $541.92 |
|
BSX
Boston Scientific Corp.
|
$5B | $0.71 | 15.97% | 105.65% | $125.86 |
|
BTSG
BrightSpring Health Services, Inc.
|
$3.2B | $0.26 | 10.79% | 359.31% | $41.93 |
|
CRL
Charles River Laboratories International, Inc.
|
$990.8M | $2.34 | -1.54% | 75.74% | $197.33 |
|
IQV
IQVIA Holdings, Inc.
|
$4.1B | $2.98 | 7.15% | 40.55% | $253.95 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.4B | $1.99 | 12.86% | 19.35% | $599.60 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
$569.98 | $541.92 | $16.1B | 39.86x | $0.00 | 0% | 7.31x |
|
BSX
Boston Scientific Corp.
|
$95.76 | $125.86 | $142B | 51.22x | $0.00 | 0% | 7.39x |
|
BTSG
BrightSpring Health Services, Inc.
|
$37.84 | $41.93 | $6.8B | 63.16x | $0.00 | 0% | 0.66x |
|
CRL
Charles River Laboratories International, Inc.
|
$203.16 | $197.33 | $10B | 913.13x | $0.00 | 0% | 2.53x |
|
IQV
IQVIA Holdings, Inc.
|
$227.11 | $253.95 | $38.7B | 31.18x | $0.00 | 0% | 2.51x |
|
ISRG
Intuitive Surgical, Inc.
|
$575.40 | $599.60 | $204B | 76.16x | $0.00 | 0% | 21.77x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
32.9% | 1.304 | 0.99% | 0.51x |
|
BSX
Boston Scientific Corp.
|
33.99% | 0.345 | 8.31% | 0.81x |
|
BTSG
BrightSpring Health Services, Inc.
|
59.75% | 3.568 | 50.52% | 0.74x |
|
CRL
Charles River Laboratories International, Inc.
|
43.59% | 1.998 | 33.97% | 0.85x |
|
IQV
IQVIA Holdings, Inc.
|
71.15% | 1.008 | 46.77% | 0.62x |
|
ISRG
Intuitive Surgical, Inc.
|
-- | 1.065 | -- | 3.42x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MEDP
Medpace Holdings, Inc.
|
$189.9M | $141.8M | 61.64% | 78.26% | 21.49% | $235.5M |
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
BTSG
BrightSpring Health Services, Inc.
|
$392M | $105.5M | 1.57% | 4.14% | 3.17% | $92.2M |
|
CRL
Charles River Laboratories International, Inc.
|
$324.7M | $151.1M | -1.27% | -2.28% | 15.04% | $178.2M |
|
IQV
IQVIA Holdings, Inc.
|
$1.1B | $572M | 6.13% | 20.65% | 13.96% | $772M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.7B | $759.7M | 16.35% | 16.38% | 30.33% | $735.6M |
Medpace Holdings, Inc. vs. Competitors
-
Which has Higher Returns MEDP or BSX?
Boston Scientific Corp. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 14.91%. Medpace Holdings, Inc.'s return on equity of 78.26% beat Boston Scientific Corp.'s return on equity of 12.46%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M BSXBoston Scientific Corp.65.31% $0.50 $35.7B -
What do Analysts Say About MEDP or BSX?
Medpace Holdings, Inc. has a consensus price target of $541.92, signalling downside risk potential of -4.92%. On the other hand Boston Scientific Corp. has an analysts' consensus of $125.86 which suggests that it could grow by 31.43%. Given that Boston Scientific Corp. has higher upside potential than Medpace Holdings, Inc., analysts believe Boston Scientific Corp. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 BSXBoston Scientific Corp.25 2 0 -
Is MEDP or BSX More Risky?
Medpace Holdings, Inc. has a beta of 1.427, which suggesting that the stock is 42.743% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.673, suggesting its less volatile than the S&P 500 by 32.691%.
-
Which is a Better Dividend Stock MEDP or BSX?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or BSX?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.1B. Medpace Holdings, Inc.'s net income of $111.1M is lower than Boston Scientific Corp.'s net income of $755M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 39.86x while Boston Scientific Corp.'s PE ratio is 51.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.31x versus 7.39x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.31x 39.86x $659.9M $111.1M BSXBoston Scientific Corp.7.39x 51.22x $5.1B $755M
-
Which has Higher Returns MEDP or BTSG?
BrightSpring Health Services, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 1.12%. Medpace Holdings, Inc.'s return on equity of 78.26% beat BrightSpring Health Services, Inc.'s return on equity of 4.14%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M BTSGBrightSpring Health Services, Inc.11.76% $0.26 $4.5B -
What do Analysts Say About MEDP or BTSG?
Medpace Holdings, Inc. has a consensus price target of $541.92, signalling downside risk potential of -4.92%. On the other hand BrightSpring Health Services, Inc. has an analysts' consensus of $41.93 which suggests that it could grow by 10.82%. Given that BrightSpring Health Services, Inc. has higher upside potential than Medpace Holdings, Inc., analysts believe BrightSpring Health Services, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 BTSGBrightSpring Health Services, Inc.14 0 0 -
Is MEDP or BTSG More Risky?
Medpace Holdings, Inc. has a beta of 1.427, which suggesting that the stock is 42.743% more volatile than S&P 500. In comparison BrightSpring Health Services, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MEDP or BTSG?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BrightSpring Health Services, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. BrightSpring Health Services, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or BTSG?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than BrightSpring Health Services, Inc. quarterly revenues of $3.3B. Medpace Holdings, Inc.'s net income of $111.1M is higher than BrightSpring Health Services, Inc.'s net income of $37.5M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 39.86x while BrightSpring Health Services, Inc.'s PE ratio is 63.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.31x versus 0.66x for BrightSpring Health Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.31x 39.86x $659.9M $111.1M BTSGBrightSpring Health Services, Inc.0.66x 63.16x $3.3B $37.5M
-
Which has Higher Returns MEDP or CRL?
Charles River Laboratories International, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 5.53%. Medpace Holdings, Inc.'s return on equity of 78.26% beat Charles River Laboratories International, Inc.'s return on equity of -2.28%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M CRLCharles River Laboratories International, Inc.32.32% $1.10 $6.1B -
What do Analysts Say About MEDP or CRL?
Medpace Holdings, Inc. has a consensus price target of $541.92, signalling downside risk potential of -4.92%. On the other hand Charles River Laboratories International, Inc. has an analysts' consensus of $197.33 which suggests that it could fall by -2.87%. Given that Medpace Holdings, Inc. has more downside risk than Charles River Laboratories International, Inc., analysts believe Charles River Laboratories International, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 CRLCharles River Laboratories International, Inc.10 7 0 -
Is MEDP or CRL More Risky?
Medpace Holdings, Inc. has a beta of 1.427, which suggesting that the stock is 42.743% more volatile than S&P 500. In comparison Charles River Laboratories International, Inc. has a beta of 1.633, suggesting its more volatile than the S&P 500 by 63.257%.
-
Which is a Better Dividend Stock MEDP or CRL?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Charles River Laboratories International, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. Charles River Laboratories International, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or CRL?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than Charles River Laboratories International, Inc. quarterly revenues of $1B. Medpace Holdings, Inc.'s net income of $111.1M is higher than Charles River Laboratories International, Inc.'s net income of $55.6M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 39.86x while Charles River Laboratories International, Inc.'s PE ratio is 913.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.31x versus 2.53x for Charles River Laboratories International, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.31x 39.86x $659.9M $111.1M CRLCharles River Laboratories International, Inc.2.53x 913.13x $1B $55.6M
-
Which has Higher Returns MEDP or IQV?
IQVIA Holdings, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 8.1%. Medpace Holdings, Inc.'s return on equity of 78.26% beat IQVIA Holdings, Inc.'s return on equity of 20.65%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M IQVIQVIA Holdings, Inc.26.49% $1.93 $21.5B -
What do Analysts Say About MEDP or IQV?
Medpace Holdings, Inc. has a consensus price target of $541.92, signalling downside risk potential of -4.92%. On the other hand IQVIA Holdings, Inc. has an analysts' consensus of $253.95 which suggests that it could grow by 11.82%. Given that IQVIA Holdings, Inc. has higher upside potential than Medpace Holdings, Inc., analysts believe IQVIA Holdings, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 IQVIQVIA Holdings, Inc.16 5 0 -
Is MEDP or IQV More Risky?
Medpace Holdings, Inc. has a beta of 1.427, which suggesting that the stock is 42.743% more volatile than S&P 500. In comparison IQVIA Holdings, Inc. has a beta of 1.366, suggesting its more volatile than the S&P 500 by 36.638%.
-
Which is a Better Dividend Stock MEDP or IQV?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IQVIA Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. IQVIA Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or IQV?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than IQVIA Holdings, Inc. quarterly revenues of $4.1B. Medpace Holdings, Inc.'s net income of $111.1M is lower than IQVIA Holdings, Inc.'s net income of $332M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 39.86x while IQVIA Holdings, Inc.'s PE ratio is 31.18x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.31x versus 2.51x for IQVIA Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.31x 39.86x $659.9M $111.1M IQVIQVIA Holdings, Inc.2.51x 31.18x $4.1B $332M
-
Which has Higher Returns MEDP or ISRG?
Intuitive Surgical, Inc. has a net margin of 16.84% compared to Medpace Holdings, Inc.'s net margin of 28.31%. Medpace Holdings, Inc.'s return on equity of 78.26% beat Intuitive Surgical, Inc.'s return on equity of 16.38%.
Company Gross Margin Earnings Per Share Invested Capital MEDPMedpace Holdings, Inc.28.78% $3.86 $437.6M ISRGIntuitive Surgical, Inc.66.36% $1.95 $17B -
What do Analysts Say About MEDP or ISRG?
Medpace Holdings, Inc. has a consensus price target of $541.92, signalling downside risk potential of -4.92%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $599.60 which suggests that it could grow by 4.21%. Given that Intuitive Surgical, Inc. has higher upside potential than Medpace Holdings, Inc., analysts believe Intuitive Surgical, Inc. is more attractive than Medpace Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings MEDPMedpace Holdings, Inc.1 8 3 ISRGIntuitive Surgical, Inc.14 11 1 -
Is MEDP or ISRG More Risky?
Medpace Holdings, Inc. has a beta of 1.427, which suggesting that the stock is 42.743% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.249%.
-
Which is a Better Dividend Stock MEDP or ISRG?
Medpace Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Medpace Holdings, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MEDP or ISRG?
Medpace Holdings, Inc. quarterly revenues are $659.9M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.5B. Medpace Holdings, Inc.'s net income of $111.1M is lower than Intuitive Surgical, Inc.'s net income of $709.2M. Notably, Medpace Holdings, Inc.'s price-to-earnings ratio is 39.86x while Intuitive Surgical, Inc.'s PE ratio is 76.16x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Medpace Holdings, Inc. is 7.31x versus 21.77x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MEDPMedpace Holdings, Inc.7.31x 39.86x $659.9M $111.1M ISRGIntuitive Surgical, Inc.21.77x 76.16x $2.5B $709.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
69
GDXU alert for Dec 30
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 18.81% over the past day.
Sell
14
SMX alert for Dec 30
SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.
Buy
63
GLTO alert for Dec 30
Galecto, Inc. [GLTO] is down 12.13% over the past day.
